Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor

Prostate

Volumn 70, Issue 15, 2010, Pages 1636-1644

  Lin, Dong ^a   Bayani, Jane ^b   Wang, Yuwei ^a   Sadar, Marianne D ^a   Yoshimoto, Maisa ^c   Gout, Peter W ^a   Squire, Jeremy A ^c   Wang, Yuzhuo ^a,d,e  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e VANCOUVER PROSTATE CENTRE   (Canada)

Author keywords

FISH; Metastasis; Prostate cancer; Xenograft

Indexed keywords

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER TISSUE; CHROMOSOME 10Q; CHROMOSOME 6P; CHROMOSOME ABERRATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; OUTCOME ASSESSMENT; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR DIFFERENTIATION; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; GENETICS; IMMUNOHISTOCHEMISTRY; METASTASIS; METHODOLOGY; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; PROSTATE TUMOR; SPECTRAL KARYOTYPING; TUMOR CELL LINE; XENOGRAFT;

AGED; ANIMALS; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; SPECTRAL KARYOTYPING; TRANSPLANTATION, HETEROLOGOUS;

EID: 77958155451     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21199     Document Type: Article

References (32)

1. Jemal A, Ward E, Hao Y, Thun M,. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294 (10): 1255 -1259.
2. Fidler IJ,. The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3 (6): 453 -458.
3. Gupta GP, Massague J,. Cancer metastasis: Building a framework. Cell 2006; 127 (4): 679 -695.
4. Arora R, Koch MO, Eble JN, Ulbright TM, Li L, Cheng L,. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer 2004; 100 (11): 2362 -2366.
5. Bostwick DG, Shan A, Qian J, Darson M, Maihle NJ, Jenkins RB, Cheng L,. Independent origin of multiple foci of prostatic intraepithelial neoplasia: Comparison with matched foci of prostate carcinoma. Cancer 1998; 83 (9): 1995 -2002.
6. Ruijter ET, van de Kaa CA, Schalken JA, Debruyne FM, Ruiter DJ,. Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol 1996; 180 (3): 295 -299.
7. Wise AM, Stamey TA, McNeal JE, Clayton JL,. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 2002; 60 (2): 264 -269.
8. Ruijter ET, Miller GJ, van de Kaa CA, van Bokhoven A, Bussemakers MJ, Debruyne FM, Ruiter DJ, Schalken JA,. Molecular analysis of multifocal prostate cancer lesions. J Pathol 1999; 188 (3): 271 -277.
9. Cheng L, Song SY, Pretlow TG, Abdul-Karim FW, Kung HJ, Dawson DV, Park WS, Moon YW, Tsai ML, Linehan WM, Emmert-Buck MR, Liotta LA, Zhuang Z,. Evidence of independent origin of multiple tumors from patients with prostate cancer. J Natl Cancer Inst 1998; 90 (3): 233 -237.
10. Barry M, Perner S, Demichelis F, Rubin MA,. TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: Clinical and biologic implications. Urology 2007; 70 (4): 630 -633.
11. Mehra R, Han B, Tomlins SA, Wang L, Menon A, Wasco MJ, Shen R, Montie JE, Chinnaiyan AM, Shah RB,. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: Molecular evidence for an independent group of diseases. Cancer Res 2007; 67 (17): 7991 -7995.
12. Ramaswamy S, Ross KN, Lander ES, Golub TR,. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003; 33 (1): 49 -54.
13. Sharpless NE, Depinho RA,. The mighty mouse: Genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 2006; 5 (9): 741 -754.
14. Voskoglou-Nomikos T, Pater JL, Seymour L,. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res 2003; 9 (11): 4227 -4239.
15. Fidler IJ,. Critical determinants of metastasis. Semin Cancer Biol 2002; 12 (2): 89 -96.
16. Wang Y, Xue H, Cutz JC, Bayani J, Mawji NR, Chen WG, Goetz LJ, Hayward SW, Sadar MD, Gilks CB, Gout PW, Squire JA, Cunha GR, Wang YZ,. An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line. Lab Invest 2005; 85 (11): 1392 -1404.
17. Wang Y, Revelo MP, Sudilovsky D, Cao M, Chen WG, Goetz L, Xue H, Sadar M, Shappell SB, Cunha GR, Hayward SW,. Development and characterization of efficient xenograft models for benign and malignant human prostate tissue. Prostate 2005; 64 (2): 149 -159.
18. Lee CH, Xue H, Sutcliffe M, Gout PW, Huntsman DG, Miller DM, Gilks CB, Wang YZ,. Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: Potential models. Gynecol Oncol 2005; 96 (1): 48 -55.
19. Cutz JC, Guan J, Bayani J, Yoshimoto M, Xue H, Sutcliffe M, English J, Flint J, LeRiche J, Yee J, Squire JA, Gout PW, Lam S, Wang YZ,. Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: Potential models for studying tumor progression-related changes. Clin Cancer Res 2006; 12 (13): 4043 -4054.
20. Bayani J, Squire JA,. Preparation of cytogenetic specimens from tissue samples. In:, Bonifacino JS, editor. Current Protocols in Cell Biology, Suppl 23. New York: John Wiley & Sons, Inc.; 2004. 22.2.1 -22.2.15.
21. Yoshimoto M, Cutz JC, Nuin PA, Joshua AM, Bayani J, Evans AJ, Zielenska M, Squire JA,. Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias. Cancer Genet Cytogenet 2006; 169 (2): 128 -137.
22. Lin D, Watahiki A, Bayani J, Zhang F, Liu L, Ling V, Sadar MD, English J, Fazli L, So A, Gout PW, Gleave M, Squire JA, Wang YZ,. ASAP1, a gene at 8q24, is associated with prostate cancer metastasis. Cancer Res 2008; 68 (11): 4352 -4359.
23. Perez-Soler R, Kemp B, Wu QP, Mao L, Gomez J, Zeleniuch-Jacquotte A, Yee H, Lee JS, Jagirdar J, Ling YH,. Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice. Clin Cancer Res 2000; 6 (12): 4932 -4938.
24. Johnson JR, Hammond WG, Benfield JR, Tesluk H,. Successful xenotransplantation of human lung cancer correlates with the metastatic phenotype. Ann Thorac Surg 1995; 60 (1): 32 -36; discussion 36-37;.
25. Fichtner I, Rolff J, Soong R, Hoffmann J, Hammer S, Sommer A, Becker M, Merk J,. Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers. Clin Cancer Res 2008; 14 (20): 6456 -6468.
26. Mattern J, Jager S, Sonka J, Wayss K, Volm M,. Growth of human bronchial carcinomas in nude mice. Br J Cancer 1985; 51 (2): 195 -200.
27. Merk J, Rolff J, Becker M, Leschber G, Fichtner I,. Patient-derived xenografts of non-small-cell lung cancer: A pre-clinical model to evaluate adjuvant chemotherapy? Eur J Cardiothorac Surg 2009; 36 (3): 454 -459.
28. Gray IC, Stewart LM, Phillips SM, Hamilton JA, Gray NE, Watson GJ, Spurr NK, Snary D,. Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN. Br J Cancer 1998; 78 (10): 1296 -1300.
29. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R,. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275 (5308): 1943 -1947.
30. Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL,. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 1998; 95 (9): 5246 -5250.
31. Fidler IJ, Kripke ML,. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977; 197 (4306): 893 -895.
32. Fidler IJ, Talmadge JE,. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Res 1986; 46 (10): 5167 -5171.